Evidence map›Paper›PMID 30232578›Full record

ReviewCurrent HIV/AIDS reports2018

Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.

Kate M Bell, Jessica E Haberer

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Real-World Implementation Challenges Associated with a Digital Pill System to Measure Adherence to HIV Pre-Exposure Prophylaxis from Two Studies of Men Who Have Sex With Men.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kate M BellCenter for Global Health, Massachusetts General Hospital, 125 Nashua St, Suite 722, Boston, MA, 02114, USA.
Jessica E HabererCenter for Global Health, Massachusetts General Hospital, 125 Nashua St, Suite 722, Boston, MA, 02114, USA. jhaberer@mgh.harvard.edu.

Funding

Real World Adherence to HIV PrEP in Serodiscordant African CouplesR01MH098744 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2013 to 2017
$3.0M
Next generation real-time monitoring for PrEP adherence in young Kenyan womenR01MH109309 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BAETEN, JARED, HABERER, JESSICA ELIZABETH · 2016 to 2019
$2.7M
Optimizing mHealth for adherence monitoring and interventionK24MH114732 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2017 to 2021
$800k
Development of Real-Time Antiretroviral Therapy Adherence Intervention in UgandaR34MH100940 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2013 to 2015
$593k
The ethics of electronic adherence monitoring for HIV research and care in UgandaR21AI108329 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI EYAL, NIR, HABERER, JESSICA ELIZABETH · 2013 to 2014
$411k
NIAID NIH HHS R21 AI108329NIMH NIH HHS K24 MH114732NIMH NIH HHS R01 MH098744NIMH NIH HHS R01 MH109309NIMH NIH HHS R34 MH100940
6 · The paper itself

Abstract

purpose of reviewCurrent digital technologies are being used for "actionable adherence monitoring"; that is, technologies that can be used to identify episodes of non-adherence to ART in a timely manner such that tailored interventions based on adherence data can be provided when and where they are needed most. RECENT

findingsCurrent digital communication technologies used to monitor ART adherence include electronic adherence monitors (EAMs), digital ingestion monitors, cellular phones, and electronic pharmacy refill tracking systems. Currently available real-time adherence monitoring approaches based on cellular technology allow for the delivery of interventions precisely when and where they are needed. Such technology can potentially enable significant efficiency of care delivery and impact on adherence and associated clinical outcomes. Standard digital advances, such as automated reminders in EAM and electronic pharmacy records, may also achieve improvements with relatively lower cost and easier implementation. Future research is needed to improve the functionality of these approaches, with attention paid to system-level issues through implementation science, as well as acceptability and ethical considerations at the individual level.

Indexed as

Clinical Pharmacy Information SystemsMedication AdherenceAnti-HIV AgentsCell PhoneHIV InfectionsHumansAnti-HIV AgentsActionable adherence monitoringAntiretroviral therapyCellular phonesDigital ingestion monitoringElectronic pharmacy refillHIV/AIDSReal-time electronic adherence monitoring

Identifiers

PMID30232578
PMCPMC6511363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.